EVH (Evolent Health) E10: $-2.15 (As of Mar. 2026)


EVH Evolent Health Inc EVH
60 GF Score
Price $5.03
GF Value $11.05
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Evolent Health E10?

Evolent Health EVH +4.79% 60 E10 is $-2.15 as of Mar. 2026. GuruFocus rates EVH with a GF Score™ of 60/100 and a GF Value™ of $11.05 (Possible Value Trap). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Evolent Health's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.240. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.15 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-24), Evolent Health's current stock price is $5.03. Evolent Health's E10 for the quarter that ended in Mar. 2026 was $-2.15. Evolent Health's Shiller PE Ratio of today is .


Evolent Health  (NYSE:EVH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Evolent Health E10 Related Terms


Evolent Health E10 Historical Data

* Premium members only.

The historical data trend for Evolent Health's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolent Health E10 Chart

Evolent Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.74 -0.72 -2.48

Evolent Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.75 -2.12 -2.11 -2.48 -2.15

EVH vs NRC, CTEV, WEAV: E10 Comparison

For the Health Information Services subindustry, Evolent Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolent Health Shiller PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Evolent Health's Shiller PE Ratio falls into.


EVH
60GF Score
Evolent Health Inc EVH
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evolent Health E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Evolent Health's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.24/330.2130*330.2130
=-0.240

Current CPI (Mar. 2026) = 330.2130.

Evolent Health Quarterly Data

per share eps CPI Adj_EPS
201606 -0.200 241.018 -0.274
201609 -0.260 241.428 -0.356
201612 -0.330 241.432 -0.451
201703 -0.340 243.801 -0.461
201706 -0.280 244.955 -0.377
201709 -0.180 246.819 -0.241
201712 -0.180 246.524 -0.241
201803 -0.180 249.554 -0.238
201806 -0.130 251.989 -0.170
201809 -0.160 252.439 -0.209
201812 -0.210 251.233 -0.276
201903 -0.590 254.202 -0.766
201906 -0.380 256.143 -0.490
201909 -0.300 256.759 -0.386
201912 -2.360 256.974 -3.033
202003 -0.930 258.115 -1.190
202006 -2.380 257.797 -3.049
202009 -0.440 260.280 -0.558
202012 -0.170 260.474 -0.216
202103 -0.120 264.877 -0.150
202106 -0.110 271.696 -0.134
202109 -0.150 274.310 -0.181
202112 -0.060 278.802 -0.071
202203 -0.060 287.504 -0.069
202206 -0.050 296.311 -0.056
202209 0.020 296.808 0.022
202212 -0.110 296.797 -0.122
202303 -0.240 301.836 -0.263
202306 -0.370 305.109 -0.400
202309 -0.300 307.789 -0.322
202312 -0.360 306.746 -0.388
202403 -0.220 312.332 -0.233
202406 -0.060 314.175 -0.063
202409 -0.270 315.301 -0.283
202412 -0.270 315.605 -0.282
202503 -0.630 319.799 -0.651
202506 -0.440 322.561 -0.450
202509 -0.240 324.800 -0.244
202512 -3.840 324.054 -3.913
202603 -0.240 330.213 -0.240

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-2.15 mean?
Evolent Health (EVH) has a E10 of $-2.15 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Evolent Health and its competitors.
Is Evolent Health's E10 too high?
Evolent Health's current E10 is $-2.15. Overall, Evolent Health has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's E10 compare to NRC and CTEV?
Evolent Health's E10 of $-2.15 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Healthcare Providers & Services company?
A good E10 depends on the Healthcare Providers & Services industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Evolent Health and its competitors. Evolent Health's current E10 is $-2.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.05, compared to a current price of $5.03 — trading 54.5% below its estimated fair value. The current E10 is $-2.15. Evolent Health's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Evolent Health (EVH), the current E10 is $-2.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evolent Health (EVH) Overvalued in 2026?

Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued. The current stock price of $5.03 is trading 54.5% below its estimated GF Value™ of $11.05. GuruFocus considers Evolent Health to be Possible Value Trap.

Key valuation signals for EVH:

  • E10: $-2.15
  • GF Value™: $11.05 vs. price of $5.03 (54.5% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Evolent Health Business Description

Other Exchanges 9EH:Germany
Address 1812 North Moore Street, Suite 1705, Arlington, VA, USA, 22209
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
60GF Score

Get the complete analysis for EVH

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.03
Price
$11.05
GF Value